Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Identification of New Multiple Myeloma-Specific Cell Surface Antigens As Immunotherapeutic Targets

Naoki Hosen, MD, PhD, Kana Hasegawa, PhD, Yasutaka Aoyama, MD, PhD, Hiroyoshi Ichihara, MD, PhD, Atsuko Mugitani, MD, PhD, Takafumi Nakao, MD PhD, Masahiro Manabe, MD, PhD, Yusuke Oji, MD, PhD, Haruo Sugiyama, MD PhD

Blood (2016) 128 (22): 3252.

https://doi.org/10.1182/blood.V128.22.3252.3252

Published: 2016

Journal Articles

Electroporation of Dicer-Substrate siRNA Duplexes Targeting Endogenous TCR Enhance Tumor Killing Activity of Wilms' Tumor 1 (WT1)-Specific TCR-Redirected Cytotoxic T Cells

Diana Campillo-Davo, MSc, Fumihiro Fujiki, PhD, Johan M.J. Van den Bergh, MSc, Evelien L. Smits, PhD, Haruo Sugiyama, MD PhD, Viggo F.I. Van Tendeloo, PhD, Zwi N. Berneman, MD PhD

Blood (2016) 128 (22): 813.

https://doi.org/10.1182/blood.V128.22.813.813

Published: 2016

Journal Articles

Clinical Phase II Study of WT1 Peptide Vaccination in Pediatric Leukemia Patients after Stem Cell Transplantation and Analysis of Immunological Monitoring

Yoshiko Hashii, MD, PhD, Yoshihiro Oka, MD, PhD, Takako Miyamura, MD, PhD, Yusuke Oji, MD, PhD, Naoki Hosen, MD, PhD, Akihiro Tsuboi, MD, PhD, Haruo Sugiyama, MD, PhD, Keiichi Ozono, MD, PhD

Blood (2014) 124 (21): 672.

https://doi.org/10.1182/blood.V124.21.672.672

Published: 2014

Journal Articles

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

Sumiko Kobayashi, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Kiyoyuki Ogata, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kensuke Usuki, MD, PhD, Kazuma Ohyashiki, MD, PhD, Keiya Ozawa, MD, PhD, Yasushi Miyazaki, MD, PhD, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD

Blood (2013) 122 (21): 2795.

https://doi.org/10.1182/blood.V122.21.2795.2795

Published: 2013

Journal Articles

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Yasuko Hamada, MD, Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Namiko Okuyama, MD, Asaka Kondo, MD, PhD, Keiichi Moriya, MD, PhD, Kiyoyuki Ogata, MD, PhD, Keiji Kakumoto, Yoshihide Miyazaki, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2799.

https://doi.org/10.1182/blood.V122.21.2799.2799

Published: 2013

Journal Articles

Clonogenic MM Progenitor Cells Reside In CD19 - CD38 ++ Plasma Cells

Naoki Hosen, MD, PhD, Haruo Sugiyama, MD, PhD

Blood (2010) 116 (21): 1897.

https://doi.org/10.1182/blood.V116.21.1897.1897

Published: 2010

Journal Articles

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

Haruo Sugiyama, MD, PhD, Akihiro Tsuboi, Yoshihiro Oka, MD, PhD, Taiichi Kyo, Yuuta Katayama, Elisseeva Olga, Manabu Kawakami, Naoki Hosen, Sumiyuki Nishida, Soyoko Morimoto, Ayako Murao, Hiroko Nakajima, Ichiro Kawase, Yusuke Oji, MD, PhD, Hiroo Dohy

Blood (2010) 116 (21): 3295.

https://doi.org/10.1182/blood.V116.21.3295.3295

Published: 2010

Journal Articles

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Blood (2010) 116 (21): 16.

https://doi.org/10.1182/blood.V116.21.16.16

Published: 2010

NARROW

Identification of New Multiple Myeloma-Specific Cell Surface Antigens As Immunotherapeutic Targets

Electroporation of Dicer-Substrate siRNA Duplexes Targeting Endogenous TCR Enhance Tumor Killing Activity of Wilms' Tumor 1 (WT1)-Specific TCR-Redirected Cytotoxic T Cells

Clinical Phase II Study of WT1 Peptide Vaccination in Pediatric Leukemia Patients after Stem Cell Transplantation and Analysis of Immunological Monitoring

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Clonogenic MM Progenitor Cells Reside In CD19 - CD38 ++ Plasma Cells

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only